3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
76
Carcinoma, Non-Small-Cell Lung
73
Multiple Myeloma
58
Prostatic Neoplasms
57
Colorectal Neoplasms
45
Leukemia, Myeloid, Acute
43
Neoplasms
41
Melanoma
35
Lymphoma
35
Lung Neoplasms
32
Ovarian Neoplasms
31
Lymphoma, Non-Hodgkin
30
Squamous Cell Carcinoma of Head and Neck
29
Sarcoma
28
Neoplasm Metastasis
27
Pancreatic Neoplasms
26
Endometrial Neoplasms
25
Carcinoma, Hepatocellular
25
Hodgkin Disease
23
Carcinoma, Renal Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Lymphoma, Large B-Cell, Diffuse
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Glioma
22
Recurrence
21
Urinary Bladder Neoplasms
20
Myelodysplastic Syndromes
20
Head and Neck Neoplasms
20
Esophageal Neoplasms
17
Stomach Neoplasms
16
Interventions
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Bronchial Neoplasms
×
30 days
×
Clear all
NCT06606847
2026-05-15
LADOGA
AstraZeneca
Phase 2
Active not recruiting
30 enrolled